Comelli M, Metelli G, Mavelli I. Downmodulation of mitochondrial F0F1 ATP synthase by diazoxide in cardiac myoblasts: a dual effect of the drug. Am J Physiol Heart Circ Physiol 292: H820 -H829, 2007; doi:10.1152/ajpheart.00366.2006.-Similar to ischemic preconditioning, diazoxide was documented to elicit beneficial bioenergetic consequences linked to cardioprotection. Inhibition of ATPase activity of mitochondrial F0F1 ATP synthase may have a role in such effect and may involve the natural inhibitor protein IF1. We recently documented, using purified enzyme and isolated mitochondrial membranes from beef heart, that diazoxide interacts with the F1 sector of F0F1 ATP synthase by promoting IF1 binding and reversibly inhibiting ATP hydrolysis. Here we investigated the effects of diazoxide on the enzyme in cultured myoblasts. Specifically, embryonic heartderived H9c2 cells were exposed to diazoxide and mitochondrial ATPase was assayed in conditions maintaining steady-state IF1 binding (basal ATPase activity) or detaching bound IF1 at alkaline pH. Mitochondrial transmembrane potential and uncoupling were also investigated, as well as ATP synthesis flux and ATP content. Diazoxide at a cardioprotective concentration (40 M cell-associated concentration) transiently downmodulated basal ATPase activity, concomitant with mild mitochondria uncoupling and depolarization, without affecting ATP synthesis and ATP content. Alkaline stripping of IF1 from F0F1 ATP synthase was less in diazoxide-treated than in untreated cells. Pretreatment with glibenclamide prevented, together with mitochondria depolarization, inhibition of ATPase activity under basal but not under IF1-stripping conditions, indicating that diazoxide alters alkaline IF1 release. Diazoxide inhibition of ATPase activity in IF1-stripping conditions was observed even when mitochondrial transmembrane potential was reduced by FCCP. The results suggest that diazoxide in a model of normoxic intact cells directly promotes binding of inhibitor protein IF1 to F0F1 ATP synthase and enhances IF1 binding indirectly by mildly uncoupling and depolarizing mitochondria. energy metabolism; H9c2 myoblasts; inhibitor protein IF 1
energy metabolism; H9c2 myoblasts; inhibitor protein IF 1 ISCHEMIC PRECONDITIONING (IPC) induces a state of cardioprotection against subsequent prolonged ischemia-reperfusion injury. The cardioprotective mechanism of IPC is complex and involves a variety of triggers that activate multiple signaling pathways, most converging on mitochondria (37) . The cellular survival program activated by IPC integrates several processes, including opening of ATP-sensitive potassium channels (20, 56) , regulation of fatty acid metabolism (28) , production of reactive oxygen species (41) , and regulation of mitochondrial permeability transition (25) . Moreover, IPC elicits protective effects on cellular bioenergetic status by downmodulating the ATPase activity of mitochondrial ATP synthase, thereby promoting cell survival after ischemic insult (2, 6, 14, 24, 43, 55) .
Pharmacological preconditioning is a cardioprotective state similar to IPC. Diazoxide, an antihypertensive and antihypoglycemic drug, is commonly used to induce preconditioning in animal models of ischemia-reperfusion (17, 20) . This hydrophobic compound passively enters cells and organelles like mitochondria. Functionally, diazoxide is commonly considered as a selective opener of mitochondrial ATP-sensitive potassium (mitoK ATP ) channels (18, 19, 20) , but at relatively high concentrations (Ͼ100 M) the drug has other effects, including the inhibition of succinate dehydrogenase (22, 48) . Interestingly, similar to IPC, diazoxide has beneficial bioenergetic consequences in perfused rat hearts and isolated rat heart mitochondria (2, 6, 33) .
Activation of mitoK ATP channels is considered to be a major trigger or end effector of IPC (19, 20, 40) , even if some authors have provided renewed support for a role of sarcolemmal K ATP channels in ischemic cardioprotection (47, 51) . Evidence for the existence of mitoK ATP channels and for their involvement in IPC derives from pharmacological studies, since K ATP channel openers (e.g., diazoxide) mimic IPC and K ATP channel blockers (e.g., glibenclamide) inhibit IPC (17, 19, 20, 23) . However, the molecular structure of mitoK ATP channels is not clear yet (12, 34) , despite recent advances in understanding its structure (3, 30) . Moreover, alternative mechanisms have been recently overviewed (4, 23) .
Mitochondrial F 0 F 1 ATP synthase is the major producer of ATP for contractile function and ionic homeostasis in cardiomyocytes (13) . When oxygen deprivation collapses the mitochondrial electrochemical gradient, F 0 F 1 ATP synthase switches from ATP synthesis to ATP hydrolysis and thus, during severe ischemia, is a major consumer of ATP (13) . Therefore, inhibition of F 0 F 1 ATP synthase during ischemia, which should conserve myocardial ATP, may play a key role in the energy-sparing effect elicited by ischemic and pharmacological preconditioning (2, 6, 24, 55) . Numerous authors have suggested that inhibition of the ATPase activity of F 0 F 1 ATP synthase is carried out by the enzyme's natural inhibitor protein, IF 1 (2, 7, 24, 55) . IF 1 is a noncompetitive inhibitor that reversibly binds with 1:1 stoichiometry to the ␤-subunit of F 1 , the catalytic sector of F 0 F 1 ATP synthase; binding requires ATP hydrolysis associated with loss of proton motive force and is favored by a low mitochondrial electrochemical gradient (32) . We recently documented (14, 43) that IF 1 binding to F 0 F 1 ATP synthase increases during IPC in goat heart in vivo. In addition, by studying both the purified enzyme and isolated mitochondrial membranes from beef heart, we demonstrated (9) that interaction of diazoxide with the ␤-subunit of the F 1 sector promotes binding with IF 1 and reversibly inhibits ATP hydrolysis. In the present study, we continued our investigation of diazoxide's effect on F 0 F 1 ATP synthase, using a biological model of embryonic heart-derived myoblasts (H9c2). We provided evidence for a dual effect of diazoxide resulting in enhancement of IF 1 binding to the enzyme and downmodulation of ATPase activity, being a mild but detectable mitochondrial depolarization and uncoupling factor triggering such binding.
METHODS

Chemicals and reagents.
All materials were purchased from Sigma (St. Louis, MO), unless otherwise stated.
Cell cultures. H9c2, a clonal line of rat embryonic heart-derived myoblasts, was obtained from American Type Culture Collection (CRL-1446; Rockville, MD). The cells were maintained in culture medium consisting of Dulbecco's modified Eagle's medium (EuroClone, Devon, United Kingdom), 10% fetal bovine serum (Biochrom, Berlin, Germany), penicillin (100 U/ml), streptomycin (100 g/ml), and glutamine (4 mM). To prevent loss of differentiation potential, cells were not allowed to become confluent and were monitored for the absence of tubular structure formation and myogenin expression. Passages 12-25 were used for all experiments described in this article. Cell density and viability were determined by Trypan blue dye exclusion test (10) .
Mitochondrial ATPase assays. H9c2 cells, grown in 10-cm tissue culture plates, were incubated in culture medium for 0 -30 min in the presence of 10 -400 M diazoxide or vehicle (0.05% dimethyl sulfoxide). In some experiments, cells were treated with carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP) for 10 min at 25 M or with vehicle (0.1% ethanol). In some experiments, cells were treated with 10 M glibenclamide for 1 h. After treatments, cells were harvested by trypsinization (0.05% trypsin, 0.02% EDTA in phosphate-buffered saline), pelleted by centrifugation, resuspended in a diazoxide-free, ice-cold solution of buffer A (mM: 1 MgCl 2, 2 EGTA, 20 HEPES pH 7.0) or buffer B (mM: 1 MgCl2, 2 EGTA, 1 NaATP, 20 HEPES pH 9.2), and homogenized by sonication (UP5OG sonifier; Hielscher, Berlin, Germany). Conditions were controlled to expose catalytic sector F 1 to solvent and to avoid uncoupling from the F0 domain (8) . Specifically, ATPase activity was monitored during ultrasonic treatment in the absence and in the presence of FCCP to evaluate breaking of mitochondria and formation of submitochondrial particles (SMP) and in the presence of oligomycin to ensure minimized damage to the enzyme coupling subunits during the treatment (7) . Homogenization at pH 7.0 maintains the binding equilibrium between IF 1 and F0F1 ATP synthase, permitting us to measure "basal" ATPase activity, while homogenization at pH 9.2 detaches 95% of bound IF 1 (46) , permitting us to measure "potential" (uninhibited) ATPase activity. Cell homogenates were assayed for ATPase immediately. SMP deprived of IF 1 were prepared accordingly to Vadineanu et al. (53) . Briefly, cells were homogenized by sonication in buffer B and centrifuged at 150,000 g for 20 min at 4°C. The resulting pellet, washed in buffer B, was then exposed to 100 M diazoxide for 10 min in buffer A or B, and ATPase activity was assayed immediately. Total protein content was determined according to Lowry et al. (36) , with bovine serum albumin as standard.
Maximal ATPase activity (V max) was determined by coupling the production of ADP to the oxidation of NADH via pyruvate kinase and lactic dehydrogenase reactions with a diazoxide-free assay buffer containing an ATP-regenerating system (mM: 50 (8) . Oligomycin concentration was chosen on the basis of a dose-dependence study of the ATPase activity inhibitory effect, which permitted us to avoid using submaximal concentrations.
Cell-associated diazoxide concentration. H9c2 cells were incubated with 100 M diazoxide in culture medium for 0 -30 min and harvested by trypsinization. Cell pellets were extracted with 0.33 N perchloric acid (500 l per 10-cm dish).
Cell-associated diazoxide concentration was determined by an HPLC method (54) using a LiChrosorb RP-8 column (10 cm ϫ 4.6 mm internal diameter; particle size, 5 m; Chrompack, Middelburg, The Netherlands). Calibration curves, obtained by adding known amounts of diazoxide to the culture medium immediately before trypsinization, were linear for the range 0.02-10 g (r ϭ 0.966); the sensitivity limit was 0.3 M. The recovery of diazoxide from perchloric acid extracts was 85.2% (SD 0.9) (n ϭ 4), based on a standard curve. Diazoxide for standard solutions was dissolved in dimethyl sulfoxide and diluted in water or culture medium to a final concentration of 0.01-0.05%.
Mitochondrial respiration assays. Mitochondrial basal respiration in intact (nonpermeabilized) H9c2 cells, treated with 100 M diazoxide or vehicle for 10 and 30 min, was measured in 3 ϫ 10 6 cells suspended in 2 ml of culture medium. O 2 consumption was measured in an oxygraphic cell at 37°C with a Clark-type O 2 electrode (Yellow Springs Instruments, Yellow Springs, OH). The solubility of O 2 was taken to be 200 nmol O 2/ml. Addition of 1 mM KCN completely suppressed O 2 consumption, indicating that mitochondrial respiration was being measured.
To assess the rate of respiration uncoupled from ATP synthesis in nonpermeabilized cells, FCCP (5 M) was added directly to the oxygraphic cell. The ratio of FCCP-stimulated respiration to basal respiration was considered as the respiratory control ratio (RCR). To assess the rate of respiration coupled to ATP synthesis (ATP synthesis flux), 10 M oligomycin was added directly to the oxygraphic chamber containing nontreated or diazoxide-treated cells; ATP synthesis flux was calculated as the difference between basal respiration rate and that measured in presence of oligomycin. FCCP and oligomycin concentrations were chosen on the basis of dose dependence studies of the respective effects on the basal respiration rate, which permitted us to avoid using submaximal concentrations.
ATP content. H9c2 cells were incubated for 10 -30 min with 100 M diazoxide, 10 min with 25 M FCCP, or with the respective vehicles in culture medium. Cells were harvested by trypsinization and extracted with 0.6 M trichloracetic acid (500 l per 10-cm dish). ATP content was determined by HPLC according to Pogolotti and Santi (44) , using a strong anion exchange column (Partisil 10 SAX; 25 cm ϫ 4.6 mm; Farmitalia, Milan, Italy). Mitochondrial transmembrane potential. Mitochondrial transmembrane potential (⌬m) was measured by confocal microscopy and flow cytometry, using the fluorescent probe 5,5Ј,6,6Ј-tetrachloro-1,1Ј,3,3Ј-tetraethylbenzimidazolylcarbocyanine iodine (JC-1; Molecular Probes, Eugene, OR). Subconfluent cultures (in 2-cm glass or 10-cm plastic culture plates) were incubated with 100 M diazoxide, 25 M FCCP, or vehicle for 10 or 30 min in culture medium. In some experiments, cells were treated with 10 M glibenclamide for 1 h. To avoid cells being differently deprived of nutrients because of the different incubation times required for the treatments, the medium was replaced with fresh complete medium containing 10 g/ml JC-1 before labeling for 5 min at 37°C in the dark.
For confocal microscopy, labeled cells were washed three times with culture medium and examined under a laser scanning confocal microscope (TCS NT; Leica, San Jose, CA). Fluorescence was excited by the 488-nm line of an argon laser, and emission was recorded at 525 and 590 nm. For quantitative analyses, pixel intensities were analyzed with MetaMorph software (Crisel Instruments, Rome, Italy).
For flow cytometry, labeled cells were harvested by trypsinization, washed three times in culture medium, resuspended at 10 6 cells/ml, and analyzed (10,000 cells/sample) with a FACScan cytometer (Becton Dickinson, Mannheim, Germany). The excitation wavelength was 488 nm, and emission was monitored at 582 nm. Data were analyzed with Cell Quest Software (Becton Dickinson, New York, NY).
Statistical analysis. Data are reported as means (SD) unless otherwise indicated. Intergroup comparisons were made with Student's t-test for two groups and by one-way ANOVA followed by post hoc Tukey's test for multiple groups. A value of P Ͻ 0.05 was considered to be statistically significant.
RESULTS
We first examined the effects elicited on the ATPase activity of mitochondrial F 0 F 1 ATP synthase by the exposure of cultured H9c2 myoblasts to diazoxide. When subconfluent cultures were homogenized at pH 7.0, ATPase activity was 0.126 U/mg (SD 0.006) (n ϭ 20). The presence of 10 M Na orthovanadate and 2 mM ouabain reduced ATPase activity by 2% and 7%, respectively, confirming that the assay conditions were specific for mitochondrial ATPase. Nevertheless, the oligomycin-sensitive ATPase activity, indicative of correctly assembled enzyme complex, was low [0.063 U/mg (SD 0.002)], although still in the range reported for cell lines assayed under experimental conditions avoiding mitochondrial isolation (5) . This may suggest that disturbed assembly/stability of F 0 F 1 ATP synthase complex occurred in H9c2 cells, considering that the homogenization conditions were carefully controlled to minimize damage to the coupling subunits of the enzyme.
When H9c2 cells were treated with 0 -400 M diazoxide for 10 min before homogenization at pH 7.0, a mild but significant dose-dependent decrease in both oligomycin-sensitive and -insensitive ATPase activity was observed at concentrations known to have cardioprotective effects (50 -200 M) (Fig. 1) . The maximum inhibitory effect (26% and 27% in the two cases) was achieved at 100 M. Diazoxide had no effect on cell viability (data not shown).
The time course analysis of the inhibitory effects of 100 M diazoxide revealed maximal reduction in ATPase activity over 10 min (Fig. 2A) . Thereafter, activity remained relatively constant until it returned to the control value at 30 min. The profile of cell-associated diazoxide during the time course paralleled that of the inhibitory effects, with a maximum concentration at 10 min (Fig. 2B) . Concentrations of cellassociated diazoxide at all time points were less than the 100 M added to the medium and below those at which the drug exerts pharmacological effects other than mitoK ATP activation (e.g., inhibition of succinate dehydrogenase).
The fact that diazoxide inhibition of ATPase was transient pointed to a reversible downmodulation of F 0 F 1 ATP synthase, probably by naturally occurring IF 1 , similar to that we previously observed on IPC (14, 43) . To test this hypothesis, taking into account that IF 1 binding to F 0 F 1 ATP synthase is optimal at pH 6.7 and that sonication at pH 9.2 releases 95% of bound IF 1 (46) , we compared mitochondrial ATPase activity in homogenates prepared at pH 7.0 and 9.2 (Fig. 3A) . In control cells (treated with vehicle), ATPase activity was only 20% higher (P Ͻ 0.05) in homogenates made at pH 9.2 (potential ATPase activity) than at pH 7.0 (basal ATPase activity), indicating a low level of bound IF 1 under physiological conditions. In cells treated with 100 M diazoxide for 10 min and homogenized at physiological pH, ATPase activity was 26% less than in nontreated cells, as shown earlier; homogenization at pH 9.2 increased ATPase activity by only 21%, similarly to nontreated cells and therefore was unable to overcome the inhibitory effects of the drug. Treatment with 25 M FCCP (to increase IF 1 binding through the loss of ⌬ m ) also inhibited ATPase by 25%, showing that free IF 1 is available in cells but in a low amount. FCCP concentrations lower than 25 M had little effect in this cell system (data not shown). Homogenization at pH 9.2 fully overcame the protonophore's inhibitory effects, returning ATPase activity to that of control cells and confirming that the inhibitory action of FCCP is due to increased IF 1 binding. FCCP treatment had no effect on cell viability, and its vehicle had no effect on ATPase activity (data not shown). Control experiments using SMP deprived of IF 1 showed that ATPase activity was not affected by diazoxide at both pH 7.0 and 9.2 (Fig. 3B) , suggesting that the drug did not interfere per se with the catalytic activity of the enzyme and confirming the role of IF 1 in the ATPase activity inhibition afforded by diazoxide.
The time course of diazoxide inhibition of mitochondrial ATPase assayed in homogenates prepared at pH 9.2 was similar to that observed in homogenates prepared at physiological pH, with a rapid and significant decrease between 0 and 10 min and recovery at 30 min (Fig. 4A) . At all time points, ATPase activity in alkaline extracts was greater than that in pH 7.0 extracts. With the consideration that alkaline treatment removes Ͼ95% of bound IF 1 (46) , the ATPase activity observed in control cells at pH 9.2 was taken as the activity of IF 1 -free enzyme. On this basis, we calculated the amount of IF 1 -inhibited enzyme as the ratio of the enzyme activity mea- sured after sonication at pH 7.0 to the value of the activity of IF 1 -free enzyme. With respect to the 20% inhibition of the ATPase activity of F 0 F 1 ATP synthase observed in nontreated cells during diazoxide treatment, we calculated 41% of IF 1 -inhibited enzyme (at 10 and 20 min), which then returned to 20% at 30 min (Fig. 4B) .
To determine whether the effects of diazoxide involved uncoupling of mitochondrial respiration, we assayed the CNsensitive O 2 consumption of intact suspended H9c2 cells. Treatment with 100 M diazoxide for 10 min, but not 30 min, significantly increased respiration, indicating a transient uncoupling effect (Fig. 5A) . Respiration in the presence of 5 M FCCP was significantly higher than in both control and diazoxide-treated cells and permitted us to confirm, on the basis of the RCR [1.8 (SD 0.2)], that the measurements were typical of intact (nonpermeabilized) cells. With the consideration that only the oligomycin-sensitive respiration, i.e., respiration coupled to ATP synthesis (ATP synthesis flux), an overall low rate [2.1 nmol O 2 ⅐min Ϫ1 ⅐mg protein Ϫ1 (SD 0.
2)] was observed in control cells. This suggests that the proton gradient driving ATP formation was not perfectly tight to oxidative phosphorylation and that the ATP synthesis control over respiration was quite low. The low coupling might depend on both basal proton leak and disturbed assembly/stability of F 0 F 1 ATP synthase complex, which we suggested above to occur in control cells on the basis of the observed low value of oligomycin-sensitive ATPase activity. When cells were incubated with 100 M diazoxide for 10 min, ATP synthesis flux increased but not significantly so. As expected, 10 min of 25 M FCCP blunted ATP synthesis flux. Finally, in cells treated with 100 M diazoxide for 10 min, cellular ATP content showed a negligible, nonsignificant increase (Fig. 5B) , while in cells treated with 25 M FCCP for 10 min ATP content was significantly reduced. Thus, in normoxic cells exposed to diazoxide, mitochondrial F 0 F 1 ATP synthase normally synthesized ATP despite a significantly reduced V max of ATP hydrolysis.
The fact that diazoxide did not reduce ATP levels agrees with its small effect on ATP synthesis flux and suggests that the transient uncoupling is too moderate to significantly alter mitochondrial energetics. If this is the case, membrane depolarization should also be moderate. Therefore, we investigated the effects of diazoxide on ⌬ m by monitoring the fluorescence intensity of the lipophilic cation JC-1. At confocal microscopy, control cells had punctuate red staining indicative of normal mitochondrial uptake of JC-1 driven by high ⌬ m (Fig. 6A ). After treatment with diazoxide (10 min, 100 M), cells maintained punctuate staining but were predominantly green with some yellow, indicative of lower ⌬ m ; quantification of red fluorescence intensity (590 nm) indicated a 23% (SD 2) decrease in ⌬ m compared with control cells. Cells treated with FCCP had blotchy greenish-yellow fluorescence, indicating lower ⌬ m but also undefined mitochondrial edges and leakage of dye. Similar results were observed at flow cytometry: diazoxide treatment for 10 min altered the peak of the red fluorescence intensity distribution (Fig. 6B) . Mean fluorescence intensity was 26% (SD 2) less than in control cells (P Ͻ 0.001), in agreement with confocal microscopy results. The intensity profile for a 30-min treatment with diazoxide was similar to that of control cells. FCCP treatment resulted in a 54% (SD 3) reduction in mean red fluorescence intensity (P Ͻ 0.001 vs. control cells). These results are in agreement with the effects of diazoxide on mitochondrial ATPase, and they suggest that diazoxide treatment of H9c2 cells moderately and transiently decreases ⌬ m , similar to its inhibition of F 0 F 1 ATP synthase.
Because of its hydrophobic nature, diazoxide passes through membranes and may interact with F 0 F 1 ATP synthase irrespectively of its effects on mitoK ATP channels or mitochondrial depolarization. To test this hypothesis, H9c2 cells were preexposed for 1 h to glibenclamide before treatment with 100 M diazoxide. When compared with no preexposure, glibenclamide treatment prevented the diazoxide-induced loss of ⌬ m , as indicated by stable JC-1 red fluorescence intensity measured with flow cytometry (Fig. 7A) ; glibenclamide alone had no effect on ⌬ m . Glibenclamide pretreatment also blocked diazoxide's time-dependent inhibition of mitochondrial ATPase activity, assessed in homogenates made at pH 7.0 ( Fig. 7B) . Thus, when mitoK ATP channels are blocked, diazoxide is unable to transiently induce mitochondrial depolarization and inhibit ATPase.
We further compared mitochondrial ATPase activity in homogenates prepared at pH 7.0 and pH 9.2 from cells subjected to various pharmacological treatments (Fig. 8) . Figure 8A demonstrates that, as already shown, ATPase activity from control and diazoxide-treated cells was ϳ20% higher (P Ͻ 0.05) in homogenates made at pH 9.2 than at pH 7.0, because of alkaline stripping of IF 1 . Pretreatment with glibenclamide blocked the inhibitory effects of diazoxide in homogenates prepared at physiological pH and did not alter the limited increase in ATPase activity observed at pH 9.2. This result suggests that diazoxide treatment altered IF 1 release from ATP synthase at alkaline pH, irrespective of the effects elicited on ⌬ m . When the experiments were repeated in presence of 25 M FCCP (Fig. 8B) , we again observed FCCP inhibition of ATPase in pH 7.0 homogenates but full recovery of ATPase activity in pH 9.2 homogenates; these results were not altered by pretreatment with glibenclamide, indicating that FCCP uncoupling stimulated IF 1 -mediated ATPase inhibition independently of the state of mitoK ATP channels. When cells were treated with both diazoxide and FCCP, there was no additive inhibitory effect on ATPase assessed in pH 7.0 homogenates, likely because of limited IF 1 availability, and the recovery of ATPase activity in alkaline homogenates was only partial (as observed with diazoxide alone). Finally, when cells were treated with both diazoxide and FCCP after preexposure to glibenclamide, ATPase activity in pH 7.0 homogenates was reduced to the same extent as without glibenclamide, indicating that the inhibition was due to FCCP uncoupling rather than to diazoxide. However, when these triply treated cells were homogenized at pH 9.2 to strip bound IF 1 , there was only modest recovery of ATPase, attributable to the inhibitory effects of diazoxide. Notably, in all four diazoxidetreated samples, ATPase activity measured after alkaline stripping of IF 1 was significantly lower than that in the Fig. 6 . Effect of diazoxide on mitochondrial transmembrane potential (⌬m). A: qualitative assessment of ⌬m. H9c2 cells grown on glass were exposed to vehicle (1), 100 M diazoxide (2), or 25 M FCCP (3) for 10 min in culture medium before replacement with medium containing 10 g/ml JC-1. After labeling for 5 min at 37°C in the dark, cells were assessed by confocal microscopy. One experiment representative of 3 is shown. B: flow cytometry analysis of ⌬m. Cells were treated with diazoxide (DZO, 1) and FCCP (2) and labeled as described in A before trypsinization and analysis with a FACScan cytometer. One experiment representative of 3 is shown.
respective nondiazoxide controls, while for all four FCCPtreated samples, there were no significant differences in such activity compared with the respective non-FCCP controls (Fig. 8) . These results show that, even in presence of a K ATP channel blocker, diazoxide interfered with alkaline release of IF 1 from F 0 F 1 ATP synthase. Furthermore, diazoxide had this effect even when IF 1 binding was increased by the depolarizing effects of FCCP.
DISCUSSION
Because an improved mitochondrial energy state is recognized to play an important role in the biochemical mechanisms of IPC and pharmacological preconditioning (2, 24, 43, 55), we used cultured rat H9c2 myoblasts to characterize the effects elicited by diazoxide on mitochondrial F 0 F 1 ATP synthase in intact cells. In this model system, under normoxic conditions, diazoxide inhibited the ATPase activity of F 0 F 1 ATP synthase in a transient manner, with a maximal effect of 26% at 100 M. This effect of diazoxide coincided with a transient and mild mitochondria uncoupling and membrane depolarization but was achieved without reducing ATP synthesis flux or cellular ATP content. Concerning ATP synthesis flux, the limitation of the experimental setup consisting of the fact that oligomycin increases proton motive force by inhibiting its dissipation by ATP synthesis as well as proton leak proportionally should be considered. Nevertheless, because diazoxide had no effect on oligomycin sensitivity of basal respiration, we can expect that the limitation was common to both control and diazoxide-treated cells, thus not altering the finding that ATP synthesis rate was not affected by diazoxide. Our finding are consistent with those of Fryer et al. (17), who found that the rate of ATP synthesis in isolated mitochondria of diazoxidetreated heart was not affected by the drug. Furthermore, the unaltered ATP levels were in accordance. The mitochondrial effects of diazoxide were blocked by pretreating cells with glibenclamide, a K ATP channel blocker. However, even in the presence of glibenclamide or FCCP (which strongly uncouples and depolarizes mitochondria), the effect of diazoxide was observed as a lower ATPase activity in homogenates prepared by sonication at pH 9.2 (i.e., by an effective way of releasing bound IF 1 ). These results suggest that diazoxide elicits its effects through interference with IF 1 binding and/or release, although other pH-dependent pharmacological effects of the drug cannot be ruled out. Moreover, these results are consistent with a dual effect of diazoxide leading to ATPase inhibition: by mildly uncoupling and depolarizing mitochondria, diazoxide indirectly favors binding of IF 1 to F 0 F 1 ATP synthase and thereby inhibits ATPase activity; in addition, diazoxide directly alters IF 1 binding/release to/from F 0 F 1 ATP synthase, as IF 1 alkaline stripping is less effective. This is in accordance with our previous report (9), in which we described a lower K d value of IF 1 binding to purified F 1 in the presence of diazoxide, although it did not influence the energization-dependent IF 1 release. The selective action of diazoxide, inhibiting the hydrolase but not the synthase activity of F 0 F 1 ATP synthase, may be responsible for the beneficial effects of pharmacological preconditioning on bioenergetics and cell survival during ischemia-reperfusion. A similar action has been reported by Grover et al. (21) for a series of selective ATPase inhibitors.
In the cell system investigated here, the maximal effect of diazoxide on F 0 F 1 ATP synthase was observed at 100 M, a relatively high concentration but nonetheless within the pharmacological range. Although some effects have been observed at lower concentrations (18, 39) , other authors have also used 100 M (1, 22) . To our knowledge, no authors have measured cell-associated concentrations of diazoxide, which may vary in different cells depending on the efficiency of drug-extruding machinery. When H9c2 cells were exposed to 100 M diazoxide, the cell-associated drug concentrations were 30 -40 M over 30 min. Therefore, in the experiments reported here, low intracellular concentrations of diazoxide should have helped avoid undesired effects such as succinate dehydrogenase inhibition (22, 48) .
Our results regarding the ability of IF 1 in inhibiting ATPase activity in rat cells in response to stimuli (i.e., diazoxide exposure) are in agreement with those of Das (13) (49) and Rouslin (45) , who both reported a 0.2 ratio of bound IF 1 to catalytic sector F 1 in rat. Finally, the modest mitochondrial uncoupling achieved with diazoxide in H9c2 cells is similar to that reported by Minners et al. (38, 39) , who indicated properly in a modest uncoupling the cellular response of preconditioning-mediated cardioprotection. The mechanism by which uncoupling of oxidative phosphorylation in preconditioning results in a beneficial adaptive mitochondrial response to cellular stress has not been established yet. It may include reduction of excessive reactive oxygen species generation in the contest of ischemia (41) , uncoupling-induced augmentation of glucose uptake (31) , and preservation of mitochondrial calcium overload (26) . Inhibition of ATPase activity of F 0 F 1 ATP synthase, due to the dual effect of diazoxide on IF 1 binding documented here, may be central to the adaptive response by attenuating ATP depletion. It should be emphasized that diazoxide elicited decrease of ⌬ m and enhancement of respiration, but not decrease of mitochondrial ATP synthesis and enhancement of ATP hydrolysis. Therefore, diazoxide cannot be considered to act as a "conventional protonophore" under the experimental conditions we used, although we cannot exclude such an effect on a different timescale. We can speculate that the expected increase of ATP hydrolysis may be counteracted by the effect altering the steady state of IF 1 binding/release to/from the F 0 F 1 ATP synthase that diazoxide afforded concomitantly, resulting in promotion of IF 1 binding and inhibition of ATPase activity. Conversely, at present we do not have a clear explanation for the finding that the expected decrease in ATP synthesis flux was undetectable.
Diazoxide uncoupling may be due to K ϩ influx induced by the opening of mitoK ATP channels and/or to the "protonophoric" effect of the drug (23, 27, 38, 39 (11, 15, 19, 20) . In this hypothesis, the induction of IF 1 binding to ATP synthase consequent to mild loss of ⌬ m afforded by diazoxide may be an additional molecular consequence of mitoK ATP channel opening, besides preservation of mitochondrial intermembrane architecture and of the normal low outer membrane permeability to ADP/ATP (15) . Our data concerning the protective effect of glibenclamide may prompt us to conclude, within a pharmacological approach, that this was the case. Nevertheless, metabolic effects of glibenclamide not related to the activity of specific K ATP channels have been reported (23) and must be considered, together with the finding that the sensitivity of mitochondrial Na ϩ and K ϩ channels to glibenclamide critically depends on factors such as Mg 2ϩ , ATP, and GTP concentrations (29, 50) .
Although mitoK ATP channels have been implicated in most studies regarding IPC and pharmacological preconditioning, there is no conclusive molecular evidence for their existence and no definitive information regarding structural properties. Studies in which mitoK ATP channels are pharmacologically manipulated, including the present study, must be interpreted with caution because of the multiple metabolic effects of drugs active at these potassium channels. As already mentioned, besides the actions on ATPase reported here and by others (2, 6, 55) and those on succinate dehydrogenase (22, 48) , diazoxide also acts as a protonophoric uncoupler (26, 27, 33) and inhibits other nucleotide-requiring cellular ATPases (16) . Furthermore, glibenclamide reduces fatty acid oxidation by inhibiting carnitine palmitoyltransferase (35) and blocks ATP-binding cassette transporters (42) and chloride channels (56) ; whether these actions, other than K ATP channel inhibitors, play a role in its ability to block diazoxide-induced preconditioning remains to be tested. Drug potency and targets may be critically dependent on the metabolic state of the cells and on the experimental conditions chosen (29) .
As reported by many authors (2, 6, 24, 55), we believe that reducing ATP hydrolysis rate in ischemia is a fundamental aspect of cardioprotection. In our opinion, both the mechanism documented by Garlid and coworkers and that suggested by us and involving a dual effect on ATP synthase may contribute to diazoxide-mediated reduction of energy waste. We therefore speculate that the modest dissipation of ⌬ m caused by diazoxide in the resting state of our cells, whether mediated by mitoK ATP channels or by other mechanisms, could be sufficient to induce IF 1 binding to ATP synthase, thereby inhibiting ATP hydrolysis catalyzed by the enzyme but not ATP synthesis. Therefore, mild uncoupling and the dual effect on ATP synthase documented by us during normoxia may represent important effects helping in the search for the mechanisms, still unknown, by which diazoxide confers cardioprotection during ischemia.
In conclusion, we observed that in normoxic intact cells, diazoxide has a dual effect on mitochondrial ATP synthase that can be summarized as follows. Diazoxide-triggered mitochondrial uncoupling and depolarization inhibit ATPase activity by promoting binding with the membrane potential-sensitive inhibitor IF 1 . Concomitantly, diazoxide interferes with the binding/release of IF 1 to/from the enzyme, further enhancing the inhibition. The transient nature of diazoxide effects we observed remains to be explained. Nevertheless, the finding that cell-associated drug concentration significantly varies over the same timescale and parallels such effects may suggest a threshold effect of the drug concentration, which appeared to diminish to the initial value at 30 min as a likely consequence of high efficiency of drug-extruding machinery. Furthermore, it should be emphasized that in fully energized mitochondria diazoxideinduced reduction of ⌬ m likely has a relatively small and transient effect, whereas under conditions of metabolic stress relatively small decreases in ⌬ m can translate into large decreases of matrix Ca 2ϩ and large changes in the functional state of mitochondria and specifically of ATPase/synthase. Under such conditions diazoxide effects may be thus amplified and made longlasting. It is also possible that a deeper investigation of the actual relevance of energy-diverting K ϩ /H ϩ cycling as a mechanism of the effects documented here (as discussed above) may provide a contribution to the explanation of their transient nature. The biological relevance of these results versus cardioprotection needs further in vivo investigation.
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